Kidneyhood | The Only Clinically Proven Kidney Disease Management Prog

Kidneyhood is the world's first integrated, clinically proven kidney disease management program — combining a very low protein diet, Albutrix keto acid analog supplementation, and Microtrix nutrition.

Recommended by KDIGO 2024 and KDOQI 2020 guidelines. Proven in human patients. Available worldwide without a prescription.

92% of patients reduced BUN levels*

80% of patients improved GFR/eGFR*

86% of patients lowered creatinine levels*

25% average GFR/eGFR improvement*

Find out how much your GFR can improve with data from 30 other patients using the Kidneyhood.org program. A FREE 16 page chapter will be emailed to you in minutes with data on every patient.

Compare Our Approach To Other Programs

* Reflects average improvement from baseline to six months.

Any statements here have not been evaluated by the FDA. Many factors will affect the results of each patient, stage of kidney disease, dietary compliance, type of kidney disease, comorbid conditions and current health are examples of these factors.

A Specialized Protein Supplement for Kidney Disease

If you have CKD, you have likely been advised to limit protein. That guidance is correct — and recent advances in nutritional science have made it possible to go further, more safely, with better outcomes.

When the body processes protein, it produces nitrogen waste that kidneys must filter. In CKD, that filtration load accelerates damage. Standard protein supplements — whey, plant protein, amino acid blends — all generate significant nitrogen waste and are not appropriate for CKD patients on a low protein protocol.

Albutrix is different. As a keto acid analog, it provides all the essential amino acids your body needs from protein — through a metabolic pathway that generates far less nitrogen. Your body gets complete nutrition. Your kidneys get meaningful relief.

Albutrix is the only protein supplement of its kind proven in human clinical studies to improve eGFR and achieve therapeutic BUN levels when used as part of the Kidneyhood integrated program.

Recommended by the World's Leading Nephrology Organizations

Both KDIGO 2024 (Kidney Disease: Improving Global Outcomes) and KDOQI 2020 (National Kidney Foundation) recommend very low protein diets supplemented with keto acid analogs for CKD patients at risk of progression.

KDIGO 2024 Practice Point 3.3.1.2 states: patients willing and able to follow a structured protocol should consider 'a very low-protein diet (0.3-0.4 g/kg body weight/d) supplemented with essential amino acids or ketoacid analogs.' KDOQI gives this same approach its highest evidence rating: Grade 1A.

The Kidneyhood program — Albutrix + Microtrix + the Kidneyhood very low protein diet — is specifically designed to implement this recommendation. It is the only integrated program proven in human patients to achieve these outcomes, available worldwide without a prescription.